Cargando…
Vasa Previa
Vasa previa refers to unprotected fetal vessels running through the membranes over the cervix. Until recently, this condition was associated with an exceedingly high perinatal mortality rate attributable to fetal exsanguination when the membranes ruptured. However, ultrasonography has made it possib...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424826/ https://www.ncbi.nlm.nih.gov/pubmed/37590981 http://dx.doi.org/10.1097/AOG.0000000000005287 |
_version_ | 1785089746359287808 |
---|---|
author | Oyelese, Yinka Javinani, Ali Shamshirsaz, Alireza A. |
author_facet | Oyelese, Yinka Javinani, Ali Shamshirsaz, Alireza A. |
author_sort | Oyelese, Yinka |
collection | PubMed |
description | Vasa previa refers to unprotected fetal vessels running through the membranes over the cervix. Until recently, this condition was associated with an exceedingly high perinatal mortality rate attributable to fetal exsanguination when the membranes ruptured. However, ultrasonography has made it possible to diagnose the condition prenatally, allowing cesarean delivery before labor or rupture of the membranes. Several recent studies have indicated excellent outcomes with prenatally diagnosed vasa previa. However, outcomes continue to be dismal when vasa previa is undiagnosed before labor. Risk factors for vasa previa include second-trimester placenta previa and low-lying placentas, velamentous cord insertion, placentas with accessory lobes, in vitro fertilization, and multifetal gestations. Recognition of individuals who are at risk and screening them will greatly decrease the mortality rate from this condition. Because of the relative rarity of vasa previa, there are no randomized controlled trials to guide management. Therefore, recommendations on the diagnosis and management of vasa previa are based largely on cohort studies and expert opinion. This Clinical Expert Series review addresses the epidemiology, pathophysiology, natural history, diagnosis and management of vasa previa, as well as innovative treatments for the condition. |
format | Online Article Text |
id | pubmed-10424826 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104248262023-08-15 Vasa Previa Oyelese, Yinka Javinani, Ali Shamshirsaz, Alireza A. Obstet Gynecol Reviews Vasa previa refers to unprotected fetal vessels running through the membranes over the cervix. Until recently, this condition was associated with an exceedingly high perinatal mortality rate attributable to fetal exsanguination when the membranes ruptured. However, ultrasonography has made it possible to diagnose the condition prenatally, allowing cesarean delivery before labor or rupture of the membranes. Several recent studies have indicated excellent outcomes with prenatally diagnosed vasa previa. However, outcomes continue to be dismal when vasa previa is undiagnosed before labor. Risk factors for vasa previa include second-trimester placenta previa and low-lying placentas, velamentous cord insertion, placentas with accessory lobes, in vitro fertilization, and multifetal gestations. Recognition of individuals who are at risk and screening them will greatly decrease the mortality rate from this condition. Because of the relative rarity of vasa previa, there are no randomized controlled trials to guide management. Therefore, recommendations on the diagnosis and management of vasa previa are based largely on cohort studies and expert opinion. This Clinical Expert Series review addresses the epidemiology, pathophysiology, natural history, diagnosis and management of vasa previa, as well as innovative treatments for the condition. Lippincott Williams & Wilkins 2023-09 2023-08-03 /pmc/articles/PMC10424826/ /pubmed/37590981 http://dx.doi.org/10.1097/AOG.0000000000005287 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Reviews Oyelese, Yinka Javinani, Ali Shamshirsaz, Alireza A. Vasa Previa |
title | Vasa Previa |
title_full | Vasa Previa |
title_fullStr | Vasa Previa |
title_full_unstemmed | Vasa Previa |
title_short | Vasa Previa |
title_sort | vasa previa |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424826/ https://www.ncbi.nlm.nih.gov/pubmed/37590981 http://dx.doi.org/10.1097/AOG.0000000000005287 |
work_keys_str_mv | AT oyeleseyinka vasaprevia AT javinaniali vasaprevia AT shamshirsazalirezaa vasaprevia |